Boston Scientific Corp. (0HOY)
LSE
42.09
-0.14 (-0.33%)
Closed
Oct 7, 2026
Day's Range
41.8342.68
52 wk Range
41.58105.83
Financial Statements - 0HOY - Boston Scientific Corp.
Revenue
3.73B▲ 24.1%
Net Income
-368.42M▼ 3316.1%Net Margin -9.9%
EBITDA
99.48M▲ 80.8%
Free Cash Flow
-16.17M▼ 110.0%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 3.73B | 3B | 4.38B | 4.45B |
| Cost of Goods | 3.51B | 2.90B | 4.03B | 3.76B |
| Gross Profit | 219.98M | 107.28M | 354.28M | 691.53M |
 Operating Expense | - | - | - | - |
| Operating Income | -147.64M | -156.02M | 1.28M | 316.77M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | -362.05M | 17.52M | -215.22M | 61.16M |
| Income Tax | 6.36M | 6.07M | 9.68M | -41.24M |
| Net Income | -368.42M | 11.45M | -224.90M | 102.40M |
| EPS Basic | -0.46 | 0.04 | -0.246 | 0.1159 |
| EPS Diluted | -0.46 | 0.04 | -0.246 | 0.1159 |
| Basic Shares Outstanding | 800.03M | 804.46M | 798M | 797.89M |
| Diluted Shares Outstanding | 800.03M | 804.46M | 798M | 797.89M |
| Ebit | - | - | - | - |
| Ebitda | 99.48M | 55.01M | 243.61M | 579.84M |
| Net Income Continuous Operations | -368.42M | 11.45M | -224.90M | 102.40M |
| Minority Interests | 402.72K | 20.72M | 28.59M | -9.93M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
